Abstract
The results of Hepatitis Delta virus (HDV) antibody determinations carried on 566 HBsAg positive serum samples from a population of 5270 Ethiopian military recruits are reported.
The prevalence of anti-HDV among apparently healthy HBsAg carriers was 5.8%. The prevalence increases with age within the available range (18–30 years). Differences might exist by area of origin and ethnic groups. The distributions of HBV markers was similar in anti HDV positive and anti HDV negative individuals, possibly due to the relatively young age of the population and/or the hyperendemic condition of the area.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
AricoS., RizzettoM., ZanettiA., DianaS., ArnoneM., AscioneA., PastoreG., AragonaM., CareddaF., MarinucciG., FarciP., CaporasoN., DenticoP., RaimondoG., CraxiA. (1985): Clinical significance of antibody to hepatitis delta virus in symptomless HBsAg carriers. - Lancet 8451: 356–358.
GoudsmithJ., Van DerWaalsF., PonzettoA., ForzaniB., CobbelarC. (1984): Infection with the hepatitis B virus associated delta agent in an isolated West-African community. - J. Trop. Med. Hyg. 87: 257–262.
Hailu K., Rapicetta, M., Rossi G.B., Bisanti L., Bekura G., Morace G., Palladino P., Di Rienzo A.M., Conti S., Bassani F., Bertolaso G., Pasquini P. (1987): Ethiopian National Hepatitis B Study. -J. Med. Vir. (in press).
MoraceG., Van DerHelmK., JilgW., DeinhardtF. (1985): Detection of hepatitis B virus DNA in serum by a rapid filtration-hybridization assay. -J. Vir. Met. 12: 235–242.
NordenfeldtE., HanssonB.G., Al-NakibB., Al-KandariS., Al-NakibW. (1983): Frequency of delta agent infections in Kuweit. - J. Infect. Dis. 148: 768.
PasquiniP., DenticoP., PanaA., TerziI. (1985): A note on prevalence of anti-delta antibodies in a sample of 5005 healthy individuals. - Boll. Ist. Sieroter. Milan. 64: 326–327.
PonzettoA., ForzaniB., Shuja ShafiM. (1984): Delta agent infection in Saudi Arabia. A general population study. In: Vyas G.N., Dienstag J.L., Hoofnagle J.H. (Eds.) Viral Hepatitis and Liver Disease. Grune and Stratton, Inc. Orlando Florida, p. 643.
RaimondoG., GalloL., PonzettoA., SmedileA., BalboA., RizzettoM. (1982): Multicentre Study of prevalence of HBV-associated delta infection and liver disease in drug-addicts. - Lancet 8266: 249–253.
RizzettoM., ShihJ., GerinJ.L. (1980): The hepatitis B virus-associated antigen: isolation from liver, development of solid-phase radioimmunoassays for antigen and antibodies and partial characterization of antigen. - J. Immunol. 125: 318–324.
ShafiM.S., PonzettoA., ForzaniB. (1983): Delta infection in Saudi Arabia. - Prog. Clin. Biol. Res. 143: 279.
ShattockA.G., KellyM.G., FieldingJ.F., ArthursY. (1982): Epidemic hepatitis B with delta antigenemia among Dublin drug-abusers. - Irish J. Med. Sci. 151: 334–338.
SmedileA., LavariniC., FarciP., AricoS., MarinucciG., DenticoP., GiulianiG., CargnelA., DelVecchio BlancoC., RizzettoM. (1983): Epidemiologic patterns of infection with the hepatitis B virus-associated delta agent in Italy. - Am. J. Epidemiol. 117: 223–229.
SteinerP.E. (1960): Cancer of the liver and cirrhosis in Transaharian Africa and USA. - Cancer 13: 1085–1166.
Author information
Authors and Affiliations
Additional information
Corresponding author.
Rights and permissions
About this article
Cite this article
Rapicetta, M., Hailu, K., Ponzetto, A. et al. Delta hepatitis virus infection in ethiopia. Eur J Epidemiol 4, 185–188 (1988). https://doi.org/10.1007/BF00144749
Issue Date:
DOI: https://doi.org/10.1007/BF00144749